Back to Trades
REED JOHN C
EVPInnovative MedicineR&DCIK 0001181561
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 5
- Companies
- 1
- Active
- 2025–2026
REED JOHN C, EVP, Innovative Medicine, R&D, has filed 4 reports across 1 company, totaling $58.3M in disclosed volume. Sales ($20.4M) outpace purchases ($0). Insider sales are common for diversification and should be read in context. All data sourced from SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| May 4 | JNJ JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | Other | $0 |
| Feb 18 | JNJ JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | $13.1M |
| Oct 20 | JNJ JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | $4.2M |
| Jul 18 | JNJ JOHNSON & JOHNSON | REED JOHN C | EVP, Innovative Medicine, R&D | Sell | $3.1M |
4 filings